MEDA Pharma

Organisation

Trials

NCT01336530
Phase 3, Terminated, 40 people, 18 Apr 2011
NCT00977483
Phase 3, Completed, 460 people, 15 Sept 2009
NCT00328601
Phase 3, Completed, 170 people, 22 May 2006

Funded papers

Effects of a Multi-Component Nutraceutical (NUT2) on the Lipid Profile in Adults with Low-to-Moderate Cardiovascular Risk: A Randomized Placebo-Controlled Trial
12 Aug 2026

Sources: api.crossref.org

Named in competing interests

Effects of a Multi-Component Nutraceutical (NUT2) on the Lipid Profile in Adults with Low-to-Moderate Cardiovascular Risk: A Randomized Placebo-Controlled Trial
Shares or equity, 12 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov